145 related articles for article (PubMed ID: 4828402)
1. [The sympathetic (adrenergic) nervous system and its importance in the eye physiology and pathology. II. Adrenergic compounds in the therapy of glaucoma].
Jabloński J
Klin Oczna; 1974 Apr; 44(4):395-400. PubMed ID: 4828402
[No Abstract] [Full Text] [Related]
2. [Present-day views on the mechanism of action and possible clinical use of adrenergic drugs in ophthalmology].
Goś R; Stankiewicz A
Klin Oczna; 1974 Mar; 44(3):287-93. PubMed ID: 4207063
[No Abstract] [Full Text] [Related]
3. Receptor paralyzing agents applied in the treatment of glaucoma simplex.
Weinstein P
Int Z Klin Pharmakol Ther Toxikol; 1969 Oct; 2(4):374-5. PubMed ID: 4391519
[No Abstract] [Full Text] [Related]
4. [Sympathetic (adrenergic) nervous system and its importance in the physiology and pathology of the eye. I. Contemporary views on processes taking place in peripheral adrenergic tissues].
Jabloński J
Klin Oczna; 1974 Mar; 44(3):281-6. PubMed ID: 4822133
[No Abstract] [Full Text] [Related]
5. [Pharmacological and histochemical studies of antiglaucomatous drugs exerting an effect on the eye's sympathetic nervous system].
Jabłoński J
Klin Oczna; 1975 Jul; 45(7):779-84. PubMed ID: 1160299
[No Abstract] [Full Text] [Related]
6. [Clinical studies conducted with a new epinephrine derivative for the treatment of glaucoma (Dipivalyl epinephrine)].
Bischoff P
Klin Monbl Augenheilkd; 1978 Apr; 172(4):565-8. PubMed ID: 349251
[TBL] [Abstract][Full Text] [Related]
7. The action of protriptyline on adrenergic mechanisms in rabbit, primate and human eyes.
Langham ME; Carmel DD
J Pharmacol Exp Ther; 1968 Oct; 163(2):368-78. PubMed ID: 4971440
[No Abstract] [Full Text] [Related]
8. Adrenergic pharmacology of aqueous humor dynamics.
Potter DE
Pharmacol Rev; 1981 Sep; 33(3):133-53. PubMed ID: 7323134
[No Abstract] [Full Text] [Related]
9. The use of sympathetic nervous system agents in the treatment of glaucoma.
Sears ML
Trans Pa Acad Ophthalmol Otolaryngol; 1978; 31(1):42-8. PubMed ID: 675777
[No Abstract] [Full Text] [Related]
10. Observations on the pharmacology of glaucoma.
Leopold IH; Duzman E
Annu Rev Pharmacol Toxicol; 1986; 26():401-26. PubMed ID: 2872854
[No Abstract] [Full Text] [Related]
11. [Adrenergic compounds and the intraocular pressure].
Nowak JZ
Klin Oczna; 1987 Apr; 89(4):171-5. PubMed ID: 3669537
[No Abstract] [Full Text] [Related]
12. Treatment of glaucoma by chemical sympathectomy with 6-hydroxydopamine.
Holland MG
Trans Am Acad Ophthalmol Otolaryngol; 1972; 76(2):437-49. PubMed ID: 4667658
[No Abstract] [Full Text] [Related]
13. Adrenergic drugs and intraocular pressure.
Potter DE; Rowland JM
Gen Pharmacol; 1981; 12(1):1-13. PubMed ID: 7250663
[No Abstract] [Full Text] [Related]
14. [Sympathomimetic and sympatholytic drugs in the therapy of glaucoma (author's transl)].
Univ-Augenklinik Würzburg
Klin Monbl Augenheilkd; 1977 Oct; 171(4):538-46. PubMed ID: 592644
[TBL] [Abstract][Full Text] [Related]
15. [Adrenergic therapy of glaucoma].
Krieglstein GK
Fortschr Ophthalmol; 1988; 85(2):125-9. PubMed ID: 2899041
[No Abstract] [Full Text] [Related]
16. Adrenergic decentralization modifies the circadian rhythm of intraocular pressure.
Braslow RA; Gregory DS
Invest Ophthalmol Vis Sci; 1987 Oct; 28(10):1730-2. PubMed ID: 3654147
[TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacology. Sympathetic amines.
Macri FJ
Eye Ear Nose Throat Mon; 1970 Nov; 49(11):510-1. PubMed ID: 4394755
[No Abstract] [Full Text] [Related]
18. Friedenwald lecture: Perspectives in glaucoma research.
Sears ML
Invest Ophthalmol Vis Sci; 1978 Jan; 17(1):6-22. PubMed ID: 413805
[No Abstract] [Full Text] [Related]
19. [Drug treatment of glaucoma].
Hoyng PF; de Jong N
Ned Tijdschr Geneeskd; 1988 Jan; 132(4):148-51. PubMed ID: 3340235
[No Abstract] [Full Text] [Related]
20. New developments in the adrenergic pharmacology of normal and glaucomatous eyes.
Langham ME
Trans Aust Coll Ophthalmol; 1969; 1():52-63. PubMed ID: 5401126
[No Abstract] [Full Text] [Related]
[Next] [New Search]
